SRL
MXCT icon

Scientech Research LLC’s MaxCyte MXCT Stock Holding History

Scientech Research LLC’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,580
Closed -$8.84K – 436
2026
Q1 		$8.84K Sell
12,580
-57
-0.5% -$53 0.01% 446
2025
Q4 		$19.6K Buy
+12,637
New +$20.2K 0.01% 467

Other funds holding MXCT

CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $201M AUM 10.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $481M AUM 73.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BFM
Brooklands Fund Management London, United Kingdom $128M AUM
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Scientech Research LLC's MXCT Position: Q2 2026 in Review

Scientech Research LLC sold out of MaxCyte (MXCT) in Q2 2026, closing a stake of 12,580 shares — an estimated $8.84K sold.

Scientech Research LLC first reported a position in MXCT in Q4 2025 and held it in 2 quarters. The position peaked at $19.6K in Q4 2025. 122 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Scientech Research LLC reported no remaining MaxCyte position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 12,580 MaxCyte shares in Q2 2026, an estimated $8.84K.
  • Scientech Research LLC first reported a position in MaxCyte in Q4 2025 and held it in 2 quarters.
  • Scientech Research LLC's MaxCyte position peaked at $19.6K in Q4 2025.
  • 122 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.